文献速递关节外科创伤骨科

反式全肩关节置换术的医院手术量与结局关系:全国性分析

Defining the Volume-Outcome Relationship in Reverse Shoulder Arthroplasty: A Nationwide Analysis.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

基于美国全国再入院数据库2011至2015年择期反式全肩关节置换术(RSA)患者数据,分析医院年手术量与90天结局的关系。研究发现高手术量中心结局更优,SSLR分析确定了与最佳90天结局相关的医院年手术量切点为54至70例/年,而成本和资源利用相关切点更高(>100例/年)。

要点

  • 高手术量中心RSA患者90天结局更优
  • 最佳90天结局相关切点为54–70例/年
  • 成本与资源利用最佳结局见于>100例/年

核心结论

  • 医院RSA手术量与90天结局存在量效关系,高手术量中心结局更优。
  • SSLR分析确定了与最佳90天结局相关的医院年手术量切点为54至70例/年。
  • 成本和资源利用相关的最佳结局见于年手术量>100例的医院。

研究设计与样本

  • 回顾性队列研究,查询全国再入院数据库2011至2015年择期RSA患者。
  • 收集医院年手术量及90天结局数据,包括再入院、翻修、并发症、住院时间、超中位费用和出院去向。
  • 采用分层特异性似然比(SSLR)分析确定医院手术量切点,并通过二项逻辑回归验证。

主要发现

  • 2011至2015年,在高手术量中心接受治疗的患者比例增加。
  • SSLR分析为每个结局生成医院手术量切点,高手术量中心结局更优。
  • 90天再入院SSLR分析产生3个医院手术量类别:1–16、17–69和≥70例/年,彼此显著不同。
  • 90天翻修类别为1–16、17–53和≥54例/年;90天并发症类别为1–9、10–68和≥69例/年。
  • 费用超过中位值有6个类别(1–5、6–25、26–47、48–71、72–105和≥106例/年),住院时间延长有5个类别(1–10、11–25、26–59、60–105和≥106例/年),非家庭出院有4个类别(1–31、32–71、72–105和≥106例/年)。

关键数值与推荐

  • 与最佳90天结局相关的医院年手术量切点为54至70例/年。
  • 成本和资源利用最佳结局见于年手术量>100例的医院。
  • 90天再入院医院手术量类别:1–16、17–69和≥70例/年。
  • 90天翻修医院手术量类别:1–16、17–53和≥54例/年。
  • 90天并发症医院手术量类别:1–9、10–68和≥69例/年。

临床怎么用

  • 研究结果可用于未来政策决策,将RSA等复杂手术集中到高手术量中心。
  • 或鼓励低手术量机构制定策略,以高手术量中心的方式运作。

局限性

  • 证据等级为治疗性IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As the utilization of reverse total shoulder arthroplasty (RSA) grows, it is increasingly important to examine the relationship between hospital volume and RSA outcomes. We hypothesized that hospitals that perform a higher volume of RSAs would have improved outcomes. We also performed stratum-specific likelihood ratio (SSLR) analysis with the aim of delineating concrete definitions of hospital volume for RSA. METHODS: The Nationwide Readmissions Database was queried for patients who had undergone elective RSA from 2011 to 2015. Annual hospital volume and 90-day outcome data were collected, including readmission, revision, complications, hospital length of stay (LOS), supramedian cost, and discharge disposition. SSLR analysis was performed to determine hospital volume cutoffs associated with increased risks for adverse events. Cutoffs generated through SSLR analysis were confirmed via binomial logistic regression. RESULTS: The proportion of patients receiving care at high-volume centers increased from 2011 to 2015. SSLR analysis produced hospital volume cutoffs for each outcome, with higher-volume centers showing improved outcomes. The volume cutoffs associated with the best rates of 90-day outcomes ranged from 54 to 70 RSAs/year, whereas cost and resource utilization cutoffs were higher, with the best outcomes in hospitals performing >100 RSAs/year. SSLR analysis of 90-day readmission produced 3 hospital volume categories (1 to 16, 17 to 69, and ≥70 RSAs/year), each significantly different from each other. These were similar to the strata for 90-day revision (1 to 16, 17 to 53, and ≥54 RSAs/year) and 90-day complications (1 to 9, 10 to 68, and ≥69 RSAs/year). SSLR analysis produced 6 hospital volume categories for cost of care over the median value (1 to 5, 6 to 25, 26 to 47, 48 to 71, 72 to 105, and ≥106 RSAs/year), 5 categories for an extended LOS (1 to 10, 11 to 25, 26 to 59, 60 to 105, and ≥106 RSAs/year), and 4 categories for non-home discharge (1 to 31, 32 to 71, 72 to 105, and ≥106 RSAs/year). CONCLUSIONS: We have defined hospital surgical volumes that maximize outcomes after RSA, likely related to surgical experience, ancillary staff familiarity, and protocolized pathways. This information may be used in future policy decisions to consolidate complex procedures, such as RSA, at high-volume destinations, or to encourage lower-volume institutions to strategize an approach to function as a higher-volume center. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Farley KX, Schwartz AM, Boden SH, et al. Defining the Volume-Outcome Relationship in Reverse Shoulder Arthroplasty: A Nationwide Analysis. J Bone Joint Surg Am. 2020. PMID: 31977820. doi:10.2106/JBJS.19.01012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。